Literature DB >> 9695019

Thrombin.

N R Goldsack1, R C Chambers, K Dabbagh, G J Laurent.   

Abstract

Thrombin is a multifunctional serine protease which plays a central role in haemostasis by regulating platelet aggregation and blood coagulation. It is formed from its precursor prothrombin following tissue injury and converts fibrinogen to fibrin in the final step of the clotting cascade. It also promotes numerous cellular effects including chemotaxis, proliferation, extracellular matrix turnover and release of cytokines. These actions of thrombin on cells have been implicated in tissue repair processes and in the pathogenesis of inflammatory and fibroproliferative disorders such as pulmonary fibrosis and atherosclerosis. Thrombin mediates its cellular effects by proteolytically activating cell surface receptors. Presently, two such receptors have been described and their roles in regulation of these functions are currently being investigated. The discovery of multiple thrombin receptors creates the possibility of selective receptor blockade of specific thrombin mediated events. New drugs with these actions should add to our current repertoire of thrombin inhibitors used to treat thrombotic diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695019     DOI: 10.1016/s1357-2725(98)00011-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  18 in total

1.  Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's disease.

Authors:  P Lewczuk; J Wiltfang; M Lange; H Jahn; H Reiber; H Ehrenreich
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  To the editor: Is von Willebrand factor a hormone that regulates a coagulation mechanism?

Authors:  Lewis S Coleman
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

Review 3.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

4.  Measurement of procoagulant platelet subpopulations in whole blood: development of an assay for population-based studies.

Authors:  Beth A Bouchard; Aimee K Paradis; Kathleen E Brummel-Ziedins
Journal:  Thromb Res       Date:  2010-06-11       Impact factor: 3.944

Review 5.  Antiplatelet therapy: thrombin receptor antagonists.

Authors:  Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Dominick J Angiolillo
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 6.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

7.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

8.  Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice.

Authors:  Anping Dong; Paul Mueller; Fanmuyi Yang; Liping Yang; Andrew Morris; Susan S Smyth
Journal:  Thromb Res       Date:  2017-09-21       Impact factor: 3.944

9.  Thrombin induces Egr-1 expression in fibroblasts involving elevation of the intracellular Ca2+ concentration, phosphorylation of ERK and activation of ternary complex factor.

Authors:  Oliver G Rössler; Gerald Thiel
Journal:  BMC Mol Biol       Date:  2009-05-11       Impact factor: 2.946

Review 10.  Platelet thrombin receptor antagonism and atherothrombosis.

Authors:  Dominick J Angiolillo; Davide Capodanno; Shinya Goto
Journal:  Eur Heart J       Date:  2009-11-30       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.